Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Constellation Pharmaceuticals Inc (CNST)

Constellation Pharmaceuticals Inc (CNST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,465,479
  • Shares Outstanding, K 33,535
  • Annual Sales, $ 0 K
  • Annual Income, $ -59,930 K
  • 60-Month Beta 7.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 22.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.72
  • Number of Estimates 5
  • High Estimate -0.68
  • Low Estimate -0.80
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +6.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.65 +63.98%
on 11/07/19
49.00 -10.82%
on 12/03/19
+15.60 (+55.52%)
since 11/06/19
3-Month
6.01 +627.12%
on 09/30/19
49.00 -10.82%
on 12/03/19
+36.28 (+488.95%)
since 09/06/19
52-Week
4.01 +991.14%
on 12/31/18
49.00 -10.82%
on 12/03/19
+37.70 (+628.33%)
since 12/06/18

Most Recent Stories

More News
Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASH to Discuss Updated Preliminary Data from the MANIFEST Clinical Trial with CPI-0610

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host an analyst/investor...

CNST : 43.70 (+2.46%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 23.55 (+0.66%)
BBC : 33.25 (+1.55%)
BBP : 43.58 (+1.46%)
GBT : 79.35 (+4.20%)
PTI : 3.55 (-6.33%)
VRTX : 223.25 (+0.08%)
CLVS : 9.61 (+8.47%)
MYOV : 16.61 (-1.01%)
CNST : 43.70 (+2.46%)
KRTX : 67.63 (+3.35%)
CRSP : 72.37 (+2.35%)
ARKG : 34.59 (+1.44%)
GNOM : 16.21 (+1.48%)
Constellation Pharmaceuticals to Participate in Upcoming Investor Conferences

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar...

CNST : 43.70 (+2.46%)
Global Nanotechnology and Nanomedicine Treatment Markets Could Reach $350 Billion by 2025

Researchers in nanomedicine are making some big-time advances according to reports in various industry journals. Nanomedicine, a relatively new but rapidly developing branch of nanotechnology (the study,...

CELGZ : 0.47 (+2.15%)
NNVC : 2.32 (-7.20%)
CNST : 43.70 (+2.46%)
AGEN : 3.91 (-3.93%)
GSK : 45.51 (+0.66%)
CELG : 108.24 (+0.10%)
Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results

-- First MANIFEST data showing signs of CPI-0610 clinical activity in JAK-inhibitor-naive myelofibrosis patients

CNST : 43.70 (+2.46%)
Here's Why Momentum Investors Will Love Constellation Pharmaceuticals, Inc. (CNST)

Does Constellation Pharmaceuticals, Inc. (CNST) have what it takes to be a top stock pick for momentum investors? Let's find out.

CNST : 43.70 (+2.46%)
Will Constellation Pharmaceuticals Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Constellation Pharmaceuticals.

CNST : 43.70 (+2.46%)
Constellation Pharmaceuticals Announces MANIFEST Data Updates Will Be Provided in Oral and Poster Sessions on December 9 at ASH

-- Company will hold investor event on December 9 at 12:30 PM

CNST : 43.70 (+2.46%)
Constellation Pharmaceuticals (CNST) Looks Good: Stock Adds 8.3% in Session

Constellation Pharmaceuticals (CNST) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ANIK : 57.48 (+0.75%)
CNST : 43.70 (+2.46%)
Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has...

CNST : 43.70 (+2.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CNST with:

Business Summary

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and...

See More

Key Turning Points

2nd Resistance Point 45.66
1st Resistance Point 44.68
Last Price 43.70
1st Support Level 42.14
2nd Support Level 40.59

See More

52-Week High 49.00
Last Price 43.70
Fibonacci 61.8% 31.81
Fibonacci 50% 26.50
Fibonacci 38.2% 21.19
52-Week Low 4.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar